[Federal Register Volume 65, Number 34 (Friday, February 18, 2000)]
[Notices]
[Page 8618]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-4007]



[[Page 8617]]

-----------------------------------------------------------------------

Part IV





Department of Health and Human Services





-----------------------------------------------------------------------



National Institutes of Health



-----------------------------------------------------------------------



Office of the Director, National Institutes of Health, Notices of 
Meeting

  Federal Register / Vol. 65, No. 34 / Friday, February 18, 2000 / 
Notices  

[[Page 8618]]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Notice of 
Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the Recombinant DNA Advisory Committee.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: Recombinant DNA Advisory Committee.
    Date: March 8-10, 2000.
    Time: March 8--9:00 am to 5:00 pm; March 9--8:00 am to 5:30 pm; 
March 10--8:00 am to 5:00 pm.
    Agenda: The meeting will be open to the public. The agenda will 
include a discussion with the Advisory Committee to the Director 
Working Group on NIH Oversight of Clinical Gene Transfer Research, 
review of novel human gene transfer protocols, continued 
deliberation about on issues involving serious adverse event 
reporting, and a topic raised by a member of the public (separate 
notice to follow). Additional information is also available at 
ORDA's web site: http://www.nih.gov/od/oba/.
    Place: National Institutes of Health, Building 31, Conference 
Room 10, Bethesda, MD 20892.
    Contact Person: Amy P. Patterson, MD, Acting Executive 
Secretary, Office of Biotechnology Activities, National Institutes 
of Health, MSC 7010, 6000 Executive Boulevard, Suite 302, Bethesda, 
MD 20892-7010, 301-496-9838.
    OMB's ``Mandatory Information Requirements for Federal 
Assistance Program Announcements'' (45 FR 39592, June 11, 1980) 
requires a statement concerning the official government programs 
contained in the Catalog of Federal Domestic Assistance. Normally 
NIH lists in its announcements the number and title of affected 
individual programs for the guidance of the public. Because the 
guidance in this notice covers virtually every NIH and Federal 
research program in which DNA recombinant molecule techniques could 
be used, it has been determined not to be cost effective or in the 
public interest to attempt to list these programs. Such a list would 
likely require several additional pages. In addition, NIH could not 
be certain that every Federal program would be included as many 
Federal agencies, as well as private organizations, both national 
and international, have elected to follow the NIH Guidelines. In 
lieu of the individual program listing, NIH invites readers to 
direct questions to the information address above about whether 
individual programs listed in the Catalog of Federal Domestic 
Assistance are affected.

    Dated: February 11, 2000.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 00-4007 Filed 2-17-00; 8:45 am]
BILLING CODE 4140-01-M